Micron Technology, Inc. (NASDAQ:MU) CFO Ronald C. Foster unloaded 20,000 shares of Micron Technology stock on the open market in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of $35.38, for a total transaction of $707,600.00. Following the completion of the transaction, the chief financial officer now directly owns 580,416 shares in the company, valued at approximately $20,535,118. Micron Technology, Inc. (NASDAQ:MU) in last trading activity decreased -1.90% to close at $33.35. Company weekly performance is -7.40% while its quarterly performance stands at 6.06%. Micron Technology, Inc. (NASDAQ:MU) is -8.84% away from its 52 week high.
Research analysts at JMP Securities lifted their price objective on shares of Skyworks Solutions Inc. (NASDAQ:SWKS) from $75.00 to $95.00 in a report released on Monday. The firm currently has a “market outperform” rating on the stock. JMP Securities’ price objective would suggest a potential upside of 37.48% from the company’s current price. On last trading day Skyworks Solutions Inc. (NASDAQ:SWKS) decreased -0.85% to close at $68.51. Its volatility for the week is 3.84% while volatility for the month is 3.26%. SWKS’s sales growth for past 5 years was 23.30% and its EPS growth for past 5 years was 33.60%. Skyworks Solutions Inc. (NASDAQ:SWKS) monthly performance is 13.09%.
On 1 December HB Fuller Co. (NYSE:FUL) announced that its leading innovative core adhesive, CHM-1088ZP, has won the inaugural OUTLOOK Asia Award, which recognizes innovative products and services for nonwoven personal care and hygiene products, made for, or by, the Asia Pacific and Indian subcontinent markets. On last trading day HB Fuller Co. (NYSE:FUL) decreased -0.48% to close at $41.12. Its volatility for the week is 2.48% while volatility for the month is 2.11%. FUL’s sales growth for past 5 years was 8.00% and its EPS growth for past 5 years was 39.00%. HB Fuller Co. (NYSE:FUL) monthly performance is -4.57%.
Repligen Corporation (NASDAQ:RGEN) CEO Walter C. Herlihy sold 51,386 shares of the stock on the open market in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $23.43, for a total transaction of $1,203,973.98. Following the sale, the chief executive officer now directly owns 496,661 shares of the company’s stock, valued at approximately $11,636,767. Repligen Corporation (NASDAQ:RGEN) has 2.10% insider ownership while its institutional ownership stands at 88.40%. In last trading activity company’s stock closed at $19.93.
BG Medicine, Inc (NASDAQ:BGMD) major shareholder Edwin M. Kania, Jr. sold 634,390 shares of the company’s stock on the open market in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $0.32, for a total value of $203,004.80. BG Medicine, Inc. (NASDAQ:BGMD) has 2.60% insider ownership while its institutional ownership stands at 45.60%. In last trading activity company’s stock closed at $0.27.